IDDAdol: Weight Management for Adolescents With IDD

Sponsor
University of Kansas Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02561754
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
110
2
3
74.2
55
0.7

Study Details

Study Description

Brief Summary

The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Enhanced Stop Light Diet (eSLD)
  • Dietary Supplement: Conventional Diet (CD)
  • Behavioral: Face-to-face (FTF)
  • Behavioral: Technology (TECH)
  • Other: iPad with FaceTime
N/A

Detailed Description

Rates of obesity and obesity related chronic health conditions are higher in adolescents with Intellectual and Developmental Disabilities (IDD) than those in the general population. Many of the negative health consequences observed in obese adults are already present in obese adolescents with IDD.

This study is a 3 group randomized trial to evaluate the intervention delivery system and type of reduced energy diet. The investigators will randomize 123 overweight/obese adolescents with mild to moderate IDD to one of 3 groups for an 18 month trial (6 month weight loss; 12 month weight maintenance):

group 1) Face-To-Face/CD

group 2) Technology delivery/CD

group 3) Technology delivery/eSLD.

All participants will receive a progressive program of physical activity. Participants on the CD diet will be asked to consume a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet. Participants on the eSLD will consume pre-packaged portion controlled meals with the addition of 5 fruits and vegetables per day.

FTF will meet with a health educator and will track progress using pen and paper records for both physical activity and diet. TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

Study Design

Study Type:
Interventional
Actual Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Weight Management for Adolescents With IDD
Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
May 12, 2020
Actual Study Completion Date :
May 5, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Face-To-Face/CD

Delivery: Face-to-face Diet: Conventional diet

Dietary Supplement: Conventional Diet (CD)
CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.

Behavioral: Face-to-face (FTF)
FTF will meet with a health educator in person and will track progress using pen and paper records for both physical activity and diet.

Experimental: Technology delivery/CD

Delivery: Technology Diet: Conventional diet

Dietary Supplement: Conventional Diet (CD)
CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.

Behavioral: Technology (TECH)
TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

Other: iPad with FaceTime
TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.

Experimental: Technology delivery/eSLD

Delivery: Technology Diet: enhanced Stop Light Diet

Dietary Supplement: Enhanced Stop Light Diet (eSLD)
eSDL includes reduced energy portion controlled meals for 6 months, encouraged consumption of lower energy shakes and 35 fruits and vegetables per week.

Behavioral: Technology (TECH)
TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

Other: iPad with FaceTime
TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.

Outcome Measures

Primary Outcome Measures

  1. Weight loss between groups randomized to FTF/CD, TECH/CD and TECH/eSLD [Change in weight from baseline to 6 months]

    Participants will be weighed in shorts and a t-shirt between 7 and 10 AM, in duplicate, on a calibrated scale to the nearest 0.1 kg.

Secondary Outcome Measures

  1. Weight change between groups randomized to FTF/CD, TECH/CD, or TECH/eSLD [Change in weight from baseline to 18 months]

    Participants will be weighed in shorts and a t-shirt between 7 and 10 AM, in duplicate, on a calibrated scale to the nearest 0.1 kg.

  2. Cost of the intervention delivery [Accumulated cost of the intervention delivery from baseline to 18 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 13-21 yrs

  • Mild (IQ of 74-50) or moderate (IQ 40-49) IDD,

  • Of sufficient functional ability to understand directions, communicate preferences (e.g. foods), wants (e.g. more to eat/drink), and needs (e.g. assistance with food preparation) through spoken language.

  • Overweight or obese (BMI ≥ 85th%ile on CDC growth charts, or waist circumference to height ratio > 0.5

  • Living at home with a parent or guardian.

  • Internet access in the home.

  • No plans to relocate outside the study area over the next 18 mos

  • Physician consent for PA and diet.

Exclusion Criteria:
  • Insulin dependent diabetes

  • Participation in a weight management program involving diet and PA in the past 6 mos

  • Eating disorders, serious food allergies, consuming special diets, aversion to common foods,

  • Diagnosis of Prader-Willi Syndrome

  • Currently pregnant, planning on/becoming pregnant during the study.

  • Unable to participate in moderate to vigorous PA.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kansas Medical Center Kansas City Kansas United States 66160
2 Energy Balance Lab, The University of Kansas Lawrence Kansas United States 66045

Sponsors and Collaborators

  • University of Kansas Medical Center
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Joseph E Donnelly, EdD, University of Kansas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT02561754
Other Study ID Numbers:
  • STUDY00001857
  • 5R01HD079642
First Posted:
Sep 28, 2015
Last Update Posted:
May 7, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Kansas Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 7, 2021